???global.info.a_carregar???
Joaquim Fernando Tomaz Rodrigues Moita Calado. Academic degrees Completed the Título de Agregado in Medicina in 2020/07/03 by Universidade Nova de Lisboa Faculdade de Ciências Médicas, Doutoramento in Medicina in 2001/07/17 by Universidade Nova de Lisboa Faculdade de Ciências Médicas and Licenciatura in Medicina in 1987/07 by Universidade de Lisboa Faculdade de Medicina. Positions Associate Professor in Universidade Nova de Lisboa Faculdade de Ciências Médicas, Assistente Graduado in Centro Hospitalar de Lisboa Central EPE, Principal Investigator in Universidade Nova de Lisboa Comprehensive Health Research Centre and Principal Investigator in Centro Hospitalar Universitário de Lisboa Central EPE Centro de Investigação. Published 41 articles in journals. Participates and/or participated as Principal investigator in 3 project(s). In his curriculum Ciência Vitae the most frequent terms in the context of scientific, technological and artistic-cultural output are: Bartter syndrome; Hypokalemia; Chloride channels; Case reports; autosomal dominant uromodulin kidney disease; genotype; phenotype; rs4293393; uromodulin; Ophthalmology; Nephrology; amyloidosis; immunotherapy; melanoma; nephritis; glucosuria; proximal tubule; SGLT2 expression; uric acid; Autosomal dominant polycystic kidney disease (ADPKD); Cystic fibrosis transmembrane conductance regulator (CFTR); Kupffer’s vesicle (KV); Polycystin-2 (PC2); Catalysis; Molecular Biology; Spectroscopy; Computer Science Applications; Physical and Theoretical Chemistry; Organic Chemistry; Inorganic Chemistry; Bartter syndrome, type 4A; BSND protein, human; hypokalemia; mutation; renal tubular transport, inborn errors; Methylmalonic Aciduria and Homocystinuria; Thrombotic Microangiopathy; Vitamin B12 Metabolism; Doenças Genéticas; Medicine(all); Anti-phospholipase A2 receptor; idiopathic membranous nephropathy; nephrotic syndrome; podocyte; Doença cardiovascular; Diabetes; Empagliflozina; Insuficiência cardíaca; Cardiovascular disease; Empagliflozin; Heart failure; TAMM-HORSFALL PROTEIN; LOCALIZATION; UROMODULIN GENE; CYSTIC KIDNEY-DISEASE; TYPE-2; CLUSTER; MCKD; DOMAIN; NEPHRONOPHTHISIS; ENCODES; PATIENT; NOMENCLATURE; REABSORPTION; GALACTOSE MALABSORPTION; SGLT2; SLC5A2; T-1095; NA+; GLUCOSE COTRANSPORTER; INHIBITOR; CLONING; Monosaccharide Transport Proteins; Humans; Glycosuria, Renal; Sequence Deletion; glucose; selective; gene; molecular-basis; diabetic-rats; galactose; transport; renal; glut2; familial; sglt2; tubules; mutations; inhibitor; malabsorption; proximal; cotransporter; recessive; glycosuria; Chromosome Mapping; Chromosomes; Human; Pair 2; Female; Genetic Heterogeneity; Male; Nephritis; Interstitial; Journal Article; Research Support; Non-U; S; Gov't; Review; Transplantation; Urology & Nephrology; Molecular Genetics ; Genomics; Nanotheragnostics; Proteomics; Oxalates; Diabetes Mellitus, Type 2; Hyperoxaluria, Primary; Hypertension; Kidney; Nephrolithiasis; acute kidney injury; C5; complement; hemolytic uremic syndrome; thrombotic microangiopathy; coenzyme Q; COQ8B; inherited retinal diseases; Mendelian diseases; retinitis pigmentosa; .
Read full resume ↓
Identification

Personal identification

Full name
Joaquim Fernando Tomaz Rodrigues Moita Calado

Citation names

  • Calado, Joaquim

Author identifiers

Ciência ID
1D14-88A8-5A5D
ORCID iD
0000-0002-1194-3392
Education
Degree Classification
2020/07/03 - 2020/07/03
Concluded
 Medicina (Título de Agregado)
Major in Medicina; Genética
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
1998/07/17 - 2001/07/17
Concluded
 Medicina (Doutoramento)
Major in Medicina; Genética
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
"Contribuição para Clonagem do Gene NPHP1 e Estudo dos Polimorfismos dos Genes ACE I/D e AGTR1 A1166C na Suscetibilidade da Nefropatia na Diabetes Mellitus Insulino Dependente" (THESIS/DISSERTATION)
 Unanimidade
1990/01/01 - 1998/07/30
Concluded
 Título de Especialista em Nefrologia pela Ordem dos Médicos e do Grau de Assistente Hospitalar de Nefrologia pelos Hospitais Civis de Lisboa (Título de especialista)
Ordem dos Médicos, Portugal

Governo da República Portuguesa Ministério da Saúde, Portugal
Dezoito vírgula nove
1981/09/01 - 1987/07
Concluded
 Medicina (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
Affiliation

Science

Category
Host institution 		Employer
2020 - Current Principal Investigator (Research) Centro Hospitalar Universitário de Lisboa Central EPE Centro de Investigação, Portugal
2013 - Current Principal Investigator (Research) Universidade NOVA de Lisboa Comprehensive Health Research Centre, Portugal
Governo da República Portuguesa Ministério da Ciência Tecnologia e Ensino Superior, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2021 - Current Associate Professor (University Teacher) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa, Portugal
2002 - 2020 Invited Assistant Professor (University Teacher) Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
Universidade Nova de Lisboa, Portugal

Other Careers

Category
Host institution 		Employer
2005 - Current Assistente graduado (Médica) Centro Hospitalar de Lisboa Central EPE, Portugal
Governo da República Portuguesa Ministério da Saúde, Portugal
Projects

Grant

Designation Funders
1998 - 2002 Angiotensin Converting Enzyme Gene Polymorphism and Genetic Susceptibility to Diabetic Nephropathy.
PRAXIS XXI / SAU / 14228 / 1998
Principal investigator
Universidade Nova de Lisboa Centro de Toxicogenómica e Saúde Humana, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Concluded

Contract

Designation Funders
2020 - Current Development of a cellular model for Familial Renal Glucosuria: evaluation of mutants and implications for the treatment of Type 2 Diabetes Mellitus
935020001
Principal investigator
Universidade Nova de Lisboa Centro de Toxicogenómica e Saúde Humana, Portugal
2011/01/01 - 2013/12/31 Strategic Project - UI 9 - 2011-2012
PEst-OE/SAU/UI0009/2011
Universidade Nova de Lisboa Medical School, Portugal

Universidade Nova de Lisboa Centro de Toxicogenómica e Saúde Humana, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2021 - Current EUROCYS Cystinuria Registry
1356 CHULC centro de investigação
Principal investigator
Centro Hospitalar Universitário de Lisboa Central EPE Centro de Investigação, Portugal
Ongoing
Outputs

Publications

Journal article
  1. Gimpel, Charlotte; Fieuws, Steffen; Hofstetter, Jonas; Pitcher, David; Vanmeerbeek, Lotte; Haeberle, Stefanie; Dachy, Angélique; et al. "Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countries". Kidney International 108 1 (2025): 105-118. https://doi.org/10.1016/j.kint.2025.02.026.
    10.1016/j.kint.2025.02.026
  2. McAnallen, Susan M; Elhassan, Elhussein A E; Stoneman, Sinead; Pinto e Vairo, Filippo; Hogan, Marie C; Hoefele, Julia; Clince, Michelle; et al. "Genotype–phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies". Nephrology Dialysis Transplantation (2025): https://doi.org/10.1093/ndt/gfaf086.
    10.1093/ndt/gfaf086
  3. Lapão, Tânia; Barata, Rui; Jorge, Cristina; Flores, Carlos; Calado, Joaquim. "Autosomal Dominant Polycystic Kidney Disease Inflammation Biomarkers in the Tolvaptan Era". International Journal of Molecular Sciences 26 3 (2025): 1121. https://doi.org/10.3390/ijms26031121.
    10.3390/ijms26031121
  4. David Kavanagh; Gianluigi Ardissino; Vicky Brocklebank; Romy N. Bouwmeester; Arvind Bagga; Rob ter Heine; Sally Johnson; et al. "Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum". Kidney International 106 6 (2024): 1038-1050. https://novaresearch.unl.pt/en/publications/82d03948-c6a0-448a-a642-1ff262bf4af0.
    10.1016/j.kint.2024.09.012
  5. Ana Belén Iglesias-Romero; Karolina Kaminska; Mathieu Quinodoz; Marc Folcher; Siying Lin; Gavin Arno; Joaquim Calado; et al. "Bi-allelic variants in COQ8B, a gene involved in the biosynthesis of coenzyme Q10, lead to non-syndromic retinitis pigmentosa". American journal of human genetics 111 10 (2024): 2299-2306. https://novaresearch.unl.pt/en/publications/afe5e4ab-160f-4351-bceb-4bf4e71b34f7.
    10.1016/j.ajhg.2024.08.005
  6. Pedro Baltazar; Antonio Ferreira de Melo Junior; Nuno Moreira Fonseca; Miguel Brito Lança; Ana Faria; Catarina O. Sequeira; Luísa Teixeira-Santos; et al. "Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity". Genes 14 (2023): 1719.
    Open access • 10.3390/genes14091719
  7. Barata, Rui; Fila, Marc; Dalla-Vale, Fabienne; Bogarin, Roberto; Nunes, Paula; Ramalho, José; Rueff, José; Calado, Joaquim. "Performance of the ACMG-AMP criteria in a large familial renal glucosuria cohort with identified SLC5A2 sequence variants". Clinical Genetics (2023): http://dx.doi.org/10.1111/cge.14395.
    10.1111/cge.14395
  8. Correia, Maria João; Pimpão, António B.; Fernandes, Dalila G. F.; Morello, Judit; Sequeira, Catarina O.; Calado, Joaquim; Antunes, Alexandra M. M.; et al. "Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine". Molecules 27 4 (2022): 1416. http://dx.doi.org/10.3390/molecules27041416.
    10.3390/molecules27041416
  9. Joaquim Calado; Rui Barata; Rita Lucas; Telma Francisco; Rui Gonçalves; Nuno Ribeiro; Fernando Nolasco. "The Kidney Genetics Clinic: delivering precision medicine for kidney patients". Portuguese Journal of Nephrology & Hypertension (2021): https://doi.org/10.32932/pjnh.2021.10.139.
    10.32932/pjnh.2021.10.139
  10. Oliveira, Inês; Jacinto, Raquel; Pestana, Sara; Nolasco, Fernando; Calado, Joaquim; Lopes, Susana Santos; Roxo-Rosa, Mónica. "Zebrafish model as a screen to prevent cyst inflation in autosomal dominant polycystic kidney disease". (2021): http://hdl.handle.net/10362/125091.
    https://doi.org/10.3390/ijms22169013
  11. Kidd, Kendrah; Vylet'al, Petr; Schaeffer, Céline; Olinger, Eric; Živná, Martina; Hodanová, Katerina; Robins, Victoria; et al. "Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations". (2020): http://hdl.handle.net/10362/104618.
    https://doi.org/10.1016/j.ekir.2020.06.029
  12. Menezes, Maria do Mar; Aires, Inês; Semedo, Luísa; Calado, Joaquim; Ribeiro, Francisco; Nolasco, Fernando. "An Atypical Presentation of Thrombotic Microangiopathy After Lung Transplant: A Case Report". Transplantation Proceedings 51 5 (2019): 1633-1635. http://dx.doi.org/10.1016/j.transproceed.2019.05.002.
    10.1016/j.transproceed.2019.05.002
  13. Monteiro, Pedro; Aguiar, Carlos; Matos, Pedro; Silva-Nunes, José; Birne, Rita; Branco, Patrícia; Calado, Joaquim; Melo, Miguel; Polónia, Jorge. "Efeito da empagliflozina para além do controlo glicémico: benefício cardiovascular em doentes com DMT2 e doença cardiovascular estabelecida". (2019): http://hdl.handle.net/10400.21/11124.
    10.1016/j.repc.2019.02.008
  14. Calado, Joaquim; Santos, Ana Rita; Aires, Inês; Lebre, Firmina; Nolasco, Fernando; Rueff, José; Ramalho, José. "The Na+-coupled glucose transporter SGLT2 interacts with its accessory unit MAP17 in vitro and their expressions overlap in the renal proximal tubule". FEBS Letters 592 19 (2018): 3317-3326. http://dx.doi.org/10.1002/1873-3468.13233.
    10.1002/1873-3468.13233
  15. Navarro, David; Azevedo, Ana; Sequeira, Sílvia; Ferreira, Ana Carina; Carvalho, Fernanda; Fidalgo, Teresa; Vilarinho, Laura; et al. "Atypical adult-onset methylmalonic acidemia and homocystinuria presenting as hemolytic uremic syndrome". (2018): http://hdl.handle.net/10400.18/6264.
    10.1007/s13730-017-0298-6
  16. Michael J Coady; Abdulah El Tarazi; René Santer; Pierre Bissonnette; Louis J Sasseville; Joaquim Calado; Yoann Lussier; et al. "MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2". Journal Of The American Society Of Nephrology 28 1 (2017): 85-93. https://novaresearch.unl.pt/en/publications/442be325-5e74-4432-8a8f-32a68c2a7aff.
    10.1681/ASN.2015111282
  17. Coady, Michael J.; El Tarazi, Abdulah; Santer, René; Bissonnette, Pierre; Sasseville, Louis J.; Calado, Joaquim; Lussier, Yoann; et al. "MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2". Journal of the American Society of Nephrology 28 1 (2016): 85-93. http://dx.doi.org/10.1681/asn.2015111282.
    10.1681/asn.2015111282
  18. Heilberg, Ita P feferman; Tótoli, Cláudia; Calado, Joaquim T omaz. "Adult presentation of Bartter syndrome type IV with erythrocytosis". (2015): http://www.scopus.com/inward/record.url?scp=84982840812&partnerID=8YFLogxK.
    https://doi.org/10.1590/S1679-45082015RC3013
  19. Meneses,Guida; Viana,Helena; Santos,Maria C.; Ferreira,Carina; Calado,Joaquim; Carvalho,Fernanda; Remedio,Francisco; Nolasco,Fernando. "Anti-phospholipase A2 receptor antibodies in the diagnosis of idiopathic membranous nephropathy". (2015): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000100008.
  20. Aires, Inês; Fila, Marc; Polidori, David; Santos, Ana Rita; Costa, Ana Brito; Calado, Joaquim. "Determination of the Renal Threshold for Glucose Excretion in Familial Renal Glucosuria". Nephron 129 4 (2015): 300-304. http://dx.doi.org/10.1159/000381677.
    10.1159/000381677
  21. Aires,Ines; Santos,Ana Rita; Bogarin,Roberto; Genc,Gurkan; Pratas,Jorge; Ozkaya,Ozan; Carvalho,Fernanda; et al. "Disruption of urate transport in familial renal glucosuria and report on SGLT2 expression in normal and pathological kidney". (2013): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692013000400006.
  22. Aires, I.; Santos, A.R.; Pratas, J.; Nolasco, F.; Calado, J.. "Hypouricaemia and hyperuricosuria in familial renal glucosuria". Clinical Kidney Journal 6 5 (2013): 523-525. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885056806&partnerID=MN8TOARS.
    10.1093/ckj/sft100
  23. Calado, Joaquim; Santer, René; Rueff, José. "Effect of kidney disease on glucose handling (including genetic defects)". Kidney International 79 (2011): S7-S13. http://dx.doi.org/10.1038/ki.2010.510.
    10.1038/ki.2010.510
  24. Joaquim Calado; René Santer; Jose Rueff. "Effect of kidney disease on glucose handling (including genetic defects)". Kidney International 79 NA (2011): S7S13-S7S13. https://novaresearch.unl.pt/en/publications/0cbfc999-af9a-4484-840e-528e1f4a2881.
  25. Aires I; Calado J. "BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus.". (2010): http://europepmc.org/abstract/med/20872321.
  26. Santer, R.; Calado, J.. "Familial renal glucosuria and SGLT2: From a Mendelian trait to a therapeutic target". Clinical Journal of the American Society of Nephrology 5 1 (2010): 133-141. http://www.scopus.com/inward/record.url?eid=2-s2.0-75749094398&partnerID=MN8TOARS.
    10.2215/CJN.04010609
  27. Fidalgo, C.; Calado, J.; Cravo, M.. "Secondary amyloidosis in a patient with long duration crohn's disease treated with infliximab". BioDrugs 24 SUPPL. 1 (2010): 15-17. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650483395&partnerID=MN8TOARS.
    10.2165/11586250-000000000-00000
  28. Calado J. "Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.". (2009): http://europepmc.org/abstract/med/19943222.
  29. Joaquim Calado. "Twenty-one additional cases of familial renal glucosuria: Absence of genetic heterogeneity, high prevalence of private mutations, and further evidence of volume depletion". Nephrology Dialysis Transplantation 23 12 (2008): 874-3879. https://novaresearch.unl.pt/en/publications/229e7ed2-120c-4ce3-ad8a-0c9cf8c1f529.
  30. Brum, S.; Rueff, J.; Santos Joao R., J.R.; Calado, J.. "Unusual adult-onset manifestation of an attenuated Bartter's syndrome type IV renal phenotype caused by a mutation in BSND [13]". Nephrology Dialysis Transplantation 22 1 (2007): 288-289. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846108259&partnerID=MN8TOARS.
    10.1093/ndt/gfl493
  31. Calado, J.; Loeffler, J.; Sakallioglu, O.; Gok, F.; Lhotta, K.; Barata, J.; Rueff, J.. "Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting". Kidney International 69 5 (2006): 852-855. http://dx.doi.org/10.1038/sj.ki.5000194.
    10.1038/sj.ki.5000194
  32. Calado, Joaquim; Gaspar, Augusta; Clemente, Carla; Rueff, José. "A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy". (2005): http://hdl.handle.net/10362/23567.
    https://doi.org/10.1186/1471-2350-6-5
  33. Calado, J.; Gaspar, A.; Clemente, C.; Rueff, J.. "A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy". BMC Medical Genetics 6 (2005): http://www.scopus.com/inward/record.url?eid=2-s2.0-26444591591&partnerID=MN8TOARS.
    10.1186/1471-2350-6-5
  34. Joaquim Calado; Soto K; Clemente C; Correia P; Rueff J. "Gene Symbol: SLC55A2. Disease: familial renal glucosuria.". Human genetics 115 2 (2004):
  35. Calado, Joaquim; Soto, Karina; Clemente, Carla; Correia, Pedro; Rueff, Jos¿. "Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria". Human Genetics 114 3 (2004): 314-316. http://dx.doi.org/10.1007/s00439-003-1054-x.
    10.1007/s00439-003-1054-x
  36. Calado, J.; Soto, K.; Clemente, C.; Correia, P.; Rueff, J.. "Gene Symbol: SLC55A2. Disease: familial renal glucosuria.". Human genetics 115 2 (2004): http://www.scopus.com/inward/record.url?eid=2-s2.0-4344695740&partnerID=MN8TOARS.
  37. Saunier, Sophie; Calado, Joaquim; Benessy, France; Silbermann, Flora; Heilig, Roland; Weissenbach, Jean; Antignac, Corinne. "Characterization of the NPHP1 Locus: Mutational Mechanism Involved in Deletions in Familial Juvenile Nephronophthisis". The American Journal of Human Genetics 66 3 (2000): 778-789. http://dx.doi.org/10.1086/302819.
    10.1086/302819
  38. M Konrad; S Saunier; Joaquim Calado; M C Gubler; M Broyer; C Antignac. "Familial juvenile nephronophthisis". Journal of molecular medicine (Berlin, Germany) 76 5 (1998): 310-6. https://novaresearch.unl.pt/en/publications/f47fe3ce-2e25-41b2-ab16-111ea1d4b6b8.
  39. Konrad, M.; Saunier, Sophie; Calado, Joaquim; Gubler, Marie-Claire; Broyer, Michel; Antignac, Corinne. "Familial juvenile nephronophthisis". Journal of Molecular Medicine 76 5 (1998): 310-316. http://dx.doi.org/10.1007/s001090050222.
    10.1007/s001090050222
  40. Saunier, S. "A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis". Human Molecular Genetics 6 13 (1997): 2317-2323. http://dx.doi.org/10.1093/hmg/6.13.2317.
    10.1093/hmg/6.13.2317
  41. Konrad, M. "Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis". Human Molecular Genetics 5 3 (1996): 367-371. http://dx.doi.org/10.1093/hmg/5.3.367.
    10.1093/hmg/5.3.367
Journal issue
  1. calado, joaquim. "Revista Portuguesa de Clínica Geral". Revista Portuguesa de Clínica Geral 40 Suplemento (2024): https://doi.org/10.32385/rpmgf.v40i.11.
    10.32385/rpmgf.v40i.11
Report
  1. Messias,Ana; Calado,Joaquim; Viana,Helena; Nolasco,Fernando. 2019. Nephrotic syndrome in a patient with metastatic melanoma: beyond the obvious. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000400013.
  2. Costa,Bernardo M; Calado,Joaquim; Navarro,David; Nolasco,Fernando. 2016. Bartter syndrome - report of an unusual late presentation case and brief review. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000100008.

Other

Other output
  1. Mutations in COQ8B are a novel cause of recessive non-syndromic retinitis pigmentosa. 2024. K Kaminska; AB Iglesias-Romero; C Santos; SY Lin; M Quinodoz; M Folcher; Joaquim Calado; et al. https://novaresearch.unl.pt/en/publications/b86276e8-a731-463c-9c6c-ba8419b9484d.
  2. Biallelic mutations in COQ8B (ADCK4) lead to non-syndromic retinitis pigmentosa in multiple families. 2024. ABI Romero; K Kaminska; Cristina Santos; S Lin; M Quinodoz; M Folcher; Joaquim Calado; et al. https://novaresearch.unl.pt/en/publications/1c9ebfdf-fc74-49c1-8cf3-f513a7fda480.
  3. Performance of the Acmg-amp Criteria in a Large Familial Renal Glucosuria Cohort with Identified Slc5a2 Sequence Variants. 2023. R Barata; M Fila; F Vale; R Bogorin; P Nunes; Ramalho JS; Jose Rueff; Joaquim Calado. https://novaresearch.unl.pt/en/publications/afe97a8e-f9db-45d9-805d-d5b3f812d4db.
  4. Alternative pathway complement activation in secondary thrombotic microangiopathies: is genetics the smoking gun?. 2019. Calado,Joaquim. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000400009.
  5. Fighting glomerular hegemony: giving the renal tubule the credits it deserves. 2018. Calado,Joaquim. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692018000100002.
  6. DETERMINATION OF THE RENAL THRESHOLD FOR GLUCOSE EXCRETION IN FAMILIAL RENAL GLUCOSURIC PATIENTS. 2014. Joaquim Calado; Jose Rueff; fernando nolasco. https://novaresearch.unl.pt/en/publications/0342ad81-7ed9-4bfa-bd2f-7b50946c6c79.
  7. It's an anti-hyperglycaemic¿ It's a diuretic¿ It's SGLT2 inhibition!. 2013. Aires,Ines; Calado,Joaquim. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-01692013000300001.